Dysport delivered another year of solid performance ... impact is mainly on the aesthetics and is primarily related to Galderma. As you remember, historically, we always have a lot of expectation ...

ZUG, Switzerland, February 14, 2025--Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in ...

Galderma’s Nemluvio is already approved for both atopic dermatitis and prurigo nodularis in the US. Image credit: Shutterstock / JHVEPhoto. Galderma has won approval from the European Commission (EC) ...

Avec Les Echos suivez en temps réel toute l'actualité financière puisée aux meilleures sources des sociétés cotées.

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...